MedTrace Logo

Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency

NCT01101087 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-12-18

No results posted yet for this study

Summary

Dialysis catheters are sites of bacterial proliferation. The purpose of this study is to determine whether or not the use of Taurolock (a catheter lock solution) can prevent bacterial peritonitis in patients undergoing peritoneal dialysis.

Conditions

  • Peritonitis
  • Catheter-related Infections
  • Renal Insufficiency

Interventions

DEVICE

Taurolock

OTHER

Placebo

Injectable sodium chloride conditioned in exactly the same manner as the experimental product.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Bernard Branger, MD · Centre Hospitalier Universitaire de Nîmes

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • France
  • French Polynesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101087 on ClinicalTrials.gov